Appropriate Use Criteria for the Use of Nuclear Medicine in Musculoskeletal Infection Imaging

2021 ◽  
pp. jnumed.121.262579
Author(s):  
Christopher Palestro ◽  
Alicia Clark ◽  
Erin Grady ◽  
Sherif Heiba ◽  
Ora Israel ◽  
...  
2020 ◽  
Author(s):  
Freimut Dankwart Juengling ◽  
Gilles Allenbach ◽  
Matthias Bruehlmeier ◽  
Bernd Klaeser ◽  
Michael Peter Wissmeyer ◽  
...  

AbstractWhile FDG-PET imaging of the brain for the differential diagnosis of dementia has been covered by the compulsory health insurance in Switzerland for more than a decade, beta-amyloid-PET just recently has been added to the catalogue of procedures that have been cleared for routine use, provided that a set of appropriate use criteria (AUC) be followed. To provide guidance to dementia care practitioners, the Swiss Society of Nuclear Medicine and the Swiss Memory Clinics jointly report a mini-review on beta-amyloid-PET and discuss the AUC set into effect by the Swiss Federal Office of Public Health, as well as their application and limitations.


2013 ◽  
Vol 9 (1) ◽  
pp. E1-E16 ◽  
Author(s):  
Keith A. Johnson ◽  
Satoshi Minoshima ◽  
Nicolaas I. Bohnen ◽  
Kevin J. Donohoe ◽  
Norman L. Foster ◽  
...  

2020 ◽  
Vol 61 (3) ◽  
pp. 375-396 ◽  
Author(s):  
Kevin J. Donohoe ◽  
Jennifer Aloff ◽  
Anca M. Avram ◽  
K.G. Bennet ◽  
Luca Giovanella ◽  
...  

Author(s):  
Lloyd W Klein ◽  
Jacqueline Tamis‐Holland ◽  
Ajay J Kirtane ◽  
H Vernon Anderson ◽  
Joaquin Cigarroa ◽  
...  

2015 ◽  
Vol 31 (3) ◽  
pp. 521-528 ◽  
Author(s):  
Thomas P. Koshy ◽  
Anand Rohatgi ◽  
Sandeep R. Das ◽  
Angela L. Price ◽  
Andres deLuna ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document